Tevogen Inc. Common Stock
TVGN
13 hedge funds and large institutions have $26.7M invested in Tevogen Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
160% more funds holding
Funds holding: 5 → 13 (+8)
0.29% less ownership
Funds ownership: 0.61% → 0.31% (-0.29%)
47% less capital invested
Capital invested by funds: $50.8M → $26.7M (-$24.1M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.1M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$2.69M |
| 3 |
CC
Centiva Capital
New York
|
+$2.56M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.47M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
FourWorld Capital Management
New York
|
-$24.8M |
| 2 |
CCP
Corbin Capital Partners
New York
|
-$24.5M |
| 3 |
CS
Clear Street
New York
|
-$4.21K |
TVGN Hedge Fund Activity: Q3 2023 in Review
13 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q3 2023, worth a combined $26.7M — down 47% from $50.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TVGN positions and 3 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $10.1M. The largest seller was FourWorld Capital Management, exiting entirely with an estimated $24.8M sold.
- 13 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $26.7M of Tevogen Inc. Common Stock stock for Q3 2023, down 47% quarter-over-quarter.
- 11 funds opened new Tevogen Inc. Common Stock positions in Q3 2023 and 3 closed out, a net change of +8 holders.
- The largest Tevogen Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $10.1M added.
- The largest Tevogen Inc. Common Stock seller in Q3 2023 was FourWorld Capital Management, an estimated $24.8M sold.
Based on aggregated 13F filings for Q3 2023.